Literature DB >> 7912154

Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.

R Einstein1, N Abdul-Hussein, T W Wong, D H Chang, R Matthews, D P Richardson.   

Abstract

1. Arterial blood pressure, heart rate and cardiac contractility were measured in pentobarbitone-anaesthetized mongrel dogs and in conscious, instrumented dogs. 2. In anaesthetized dogs (n = 5), dose-response curves were obtained by intravenous infusion of increasing doses of dopexamine (5-20 micrograms kg-1 min-1). Infusions were administered three times to each animal to determine whether the responses were reproducible. Dopexamine increased heart rate and myocardial contractility and decreased blood pressure. The dose-response curves for dopexamine did not differ significantly over time. 3. In a second group of dogs (n = 6), dose-response curves (5-20 mg kg-1 min-1) were obtained as above and repeated after the administration of amitriptyline (2 mg kg-1, i.v.). Amitriptyline caused a non-significant reduction in the inotropic and chronotropic responses to dopexamine. 4. Control dose-response curves for dopexamine (5-50 micrograms kg-1 min-1) were similarly obtained in a third group of dogs (n = 6), and repeated after bilateral vagotomy and sympathetic denervation of the heart. In these animals, a third dose-response curve for dopexamine was obtained after the administration of ICI 118551 (0.2 mg kg-1, followed by 0.2 mg kg-1 h-1). The chronotropic response to dopexamine was significantly reduced after cardiac denervation. There was a small, non-significant reduction in the inotropic and depressor responses after denervation. Administration of ICI 115881 significantly reduced both the inotropic and chronotropic response to dopexamine and caused a non-significant reduction in the depressor response. 5. The effect of raclopride (0.2 mumol kg-1, p.o.) was investigated by comparison of the dose-response curves for dopexamine in a control group of dogs (n = 6) to those obtained in dogs which had been pretreated with raclopride (n = 5). Raclopride had no significant effect on the cardiovascular responses to dopexamine. 6. In conscious, instrumented dogs (n = 5), pretreated with raclopride, dose-related positive inotropic and chronotropic and depressor responses to dopexamine infusions were recorded. The chronotropic responses in conscious animals were significantly greater than those in the anaesthetized animals.7. The results of this study indicate that both the positive inotropic and chronotropic actions of dopamine are due to a combination of direct, Beta2-adrenoceptor-mediated effects and the baroreceptor reflex response to the depressor action of the drug.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912154      PMCID: PMC1910026          DOI: 10.1111/j.1476-5381.1994.tb14044.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

Review 1.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).

Authors:  G W Smith; S E O'Connor
Journal:  Am J Cardiol       Date:  1988-08-11       Impact factor: 2.778

3.  A device for measuring myocardial contractility.

Authors:  A H Goodman; J A Angus; R Einstein; L B Cobbin
Journal:  Med Biol Eng       Date:  1972-07

4.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

5.  Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.

Authors:  A S Bass; J D Kohli; N Lubbers; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

6.  The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.

Authors:  G W Smith; J C Hall; J B Farmer; W T Simpson
Journal:  J Pharm Pharmacol       Date:  1987-08       Impact factor: 3.765

7.  Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.

Authors:  J D Kohli; D Glock; L I Goldberg
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

8.  Inhibition of Uptake1 by dopexamine hydrochloride in vitro.

Authors:  P D Mitchell; G W Smith; E Wells; P A West
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

9.  The effects of dopexamine on the cardiovascular system of the dog.

Authors:  R A Brown; J B Farmer; J C Hall; R G Humphries; S E O'Connor; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

10.  Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo.

Authors:  S B Ross; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.